US Stock MarketDetailed Quotes

TMO Thermo Fisher Scientific

Watchlist
  • 529.140
  • -4.150-0.78%
Trading Feb 27 12:48 ET
199.62BMarket Cap32.01P/E (TTM)

Thermo Fisher Scientific Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 29, 2024
(Q1)Mar 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jul 1, 2023
(Q1)Apr 1, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.10%8.67B
-11.60%3.29B
-10.40%2.16B
27.47%1.96B
71.47%1.25B
-8.17%8.41B
6.77%3.72B
24.63%2.41B
0.79%1.54B
729M
Net income from continuing operations
6.43%6.34B
13.57%1.82B
-3.89%1.63B
14.10%1.55B
3.02%1.33B
-14.44%5.96B
2.03%1.61B
13.15%1.7B
-18.35%1.36B
--1.29B
Depreciation and amortization
-8.75%3.11B
-11.56%742M
-13.36%739M
-7.49%791M
-2.68%836M
0.74%3.41B
-1.06%839M
1.79%853M
2.27%855M
--859M
Deferred tax
7.00%-1.21B
69.81%-202M
-32.01%-400M
-94.51%-354M
-73.29%-253M
-30.65%-1.3B
-403.01%-669M
-16.09%-303M
30.53%-182M
---146M
Other non cash items
-17.62%463M
71.90%208M
-9.91%100M
-32.21%101M
-70.17%54M
10.41%562M
83.33%121M
-26.97%111M
156.90%149M
--181M
Change In working capital
32.53%-334M
-63.80%639M
433.33%30M
69.92%-216M
48.66%-787M
50.89%-495M
62.97%1.77B
97.55%-9M
15.43%-718M
---1.53B
-Change in receivables
-297.67%-171M
----
----
----
----
90.00%-43M
----
----
----
----
-Change in inventory
-104.52%-27M
----
----
----
----
172.48%598M
----
----
----
----
-Change in payables and accrued expense
142.40%212M
----
----
----
----
-177.16%-500M
----
----
----
----
-Change in other working capital
36.73%-348M
----
----
----
----
-37.16%-550M
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
3.10%8.67B
-11.63%3.29B
-10.27%2.17B
27.27%1.96B
71.60%1.25B
-8.17%8.41B
6.77%3.72B
24.63%2.41B
0.79%1.54B
--729M
Investing cash flow
Cash flow from continuing investing activities
-13.59%-5.84B
105.05%19M
-202.88%-3.58B
42.89%-253M
35.39%-2.03B
-138.17%-5.14B
28.38%-376M
-116.70%-1.18B
-5.73%-443M
-3.14B
Net PPE purchase and sale
3.52%-1.34B
-17.51%-463M
5.26%-252M
-1.79%-285M
24.12%-343M
37.27%-1.39B
27.57%-394M
51.01%-266M
43.32%-280M
---452M
Net business purchase and sale
14.43%-3.13B
--0
-244.55%-3.13B
--0
--0
-9,284.62%-3.66B
--0
-91,000.00%-909M
---47M
---2.7B
Net investment purchase and sale
-1,017.07%-1.37B
1,090.24%488M
-1,672.73%-195M
117.65%27M
---1.69B
-255.70%-123M
--41M
---11M
---153M
--0
Net other investing changes
-75.76%8M
78.26%-5M
-80.00%1M
-86.49%5M
-50.00%7M
65.00%33M
61.67%-23M
266.67%5M
-50.67%37M
--14M
Cash from discontinued investing activities
Investing cash flow
-13.59%-5.84B
105.32%20M
-202.96%-3.58B
42.89%-253M
35.39%-2.03B
-138.17%-5.14B
28.38%-376M
-116.70%-1.18B
-5.73%-443M
---3.14B
Financing cash flow
Cash flow from continuing financing activities
-87.49%-6.79B
-156.72%-3.67B
-164.15%-1.19B
92.10%-115M
29.81%-1.82B
-28.90%-3.62B
-159.72%-1.43B
1,328.48%1.86B
23.57%-1.46B
-2.59B
Net issuance payments of debt
-1,450.32%-2.4B
-91.42%-2.5B
-156.14%-1.11B
99.92%-1M
139.09%1.21B
-123.70%-155M
-137.44%-1.31B
197,300.00%1.97B
27.40%-1.33B
--504M
Net common stock issuance
-33.33%-4B
---1B
--0
--0
0.00%-3B
0.00%-3B
--0
--0
--0
---3B
Cash dividends paid
-11.47%-583M
-9.56%-149M
-11.11%-150M
-10.37%-149M
-15.38%-135M
-14.95%-523M
-16.24%-136M
-14.41%-135M
-15.38%-135M
---117M
Net other financing activities
246.43%194M
-221.43%-17M
272.22%67M
775.00%35M
445.00%109M
722.22%56M
-30.00%14M
156.25%18M
-89.19%4M
--20M
Cash from discontinued financing activities
Financing cash flow
-87.52%-6.79B
-156.72%-3.67B
-164.15%-1.19B
92.10%-115M
29.77%-1.82B
-28.90%-3.62B
-159.72%-1.43B
1,328.48%1.86B
23.57%-1.46B
---2.59B
Net cash flow
Beginning cash position
-5.15%8.1B
-24.29%4.67B
125.09%7.1B
57.69%5.52B
-5.15%8.1B
90.09%8.54B
110.22%6.17B
65.51%3.15B
25.94%3.5B
--8.54B
Current changes in cash
-1,007.82%-3.97B
-118.60%-357M
-184.26%-2.6B
543.73%1.59B
48.06%-2.6B
-108.55%-358M
-64.15%1.92B
148.83%3.09B
54.90%-359M
---5.01B
Effect of exchange rate changes
-10.98%-91M
-2,830.00%-273M
339.73%175M
-225.00%-15M
170.97%22M
41.01%-82M
-96.00%10M
65.57%-73M
115.38%12M
---31M
End cash Position
-50.10%4.04B
-50.10%4.04B
-24.29%4.67B
125.09%7.1B
57.69%5.52B
-5.15%8.1B
-5.15%8.1B
110.22%6.17B
65.51%3.15B
--3.5B
Free cash flow
4.91%7.27B
-15.31%2.81B
-9.03%1.89B
32.09%1.66B
233.58%904M
0.23%6.93B
12.97%3.32B
49.78%2.08B
22.90%1.26B
--271M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 29, 2024(Q1)Mar 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jul 1, 2023(Q1)Apr 1, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.10%8.67B-11.60%3.29B-10.40%2.16B27.47%1.96B71.47%1.25B-8.17%8.41B6.77%3.72B24.63%2.41B0.79%1.54B729M
Net income from continuing operations 6.43%6.34B13.57%1.82B-3.89%1.63B14.10%1.55B3.02%1.33B-14.44%5.96B2.03%1.61B13.15%1.7B-18.35%1.36B--1.29B
Depreciation and amortization -8.75%3.11B-11.56%742M-13.36%739M-7.49%791M-2.68%836M0.74%3.41B-1.06%839M1.79%853M2.27%855M--859M
Deferred tax 7.00%-1.21B69.81%-202M-32.01%-400M-94.51%-354M-73.29%-253M-30.65%-1.3B-403.01%-669M-16.09%-303M30.53%-182M---146M
Other non cash items -17.62%463M71.90%208M-9.91%100M-32.21%101M-70.17%54M10.41%562M83.33%121M-26.97%111M156.90%149M--181M
Change In working capital 32.53%-334M-63.80%639M433.33%30M69.92%-216M48.66%-787M50.89%-495M62.97%1.77B97.55%-9M15.43%-718M---1.53B
-Change in receivables -297.67%-171M----------------90.00%-43M----------------
-Change in inventory -104.52%-27M----------------172.48%598M----------------
-Change in payables and accrued expense 142.40%212M-----------------177.16%-500M----------------
-Change in other working capital 36.73%-348M-----------------37.16%-550M----------------
Cash from discontinued investing activities
Operating cash flow 3.10%8.67B-11.63%3.29B-10.27%2.17B27.27%1.96B71.60%1.25B-8.17%8.41B6.77%3.72B24.63%2.41B0.79%1.54B--729M
Investing cash flow
Cash flow from continuing investing activities -13.59%-5.84B105.05%19M-202.88%-3.58B42.89%-253M35.39%-2.03B-138.17%-5.14B28.38%-376M-116.70%-1.18B-5.73%-443M-3.14B
Net PPE purchase and sale 3.52%-1.34B-17.51%-463M5.26%-252M-1.79%-285M24.12%-343M37.27%-1.39B27.57%-394M51.01%-266M43.32%-280M---452M
Net business purchase and sale 14.43%-3.13B--0-244.55%-3.13B--0--0-9,284.62%-3.66B--0-91,000.00%-909M---47M---2.7B
Net investment purchase and sale -1,017.07%-1.37B1,090.24%488M-1,672.73%-195M117.65%27M---1.69B-255.70%-123M--41M---11M---153M--0
Net other investing changes -75.76%8M78.26%-5M-80.00%1M-86.49%5M-50.00%7M65.00%33M61.67%-23M266.67%5M-50.67%37M--14M
Cash from discontinued investing activities
Investing cash flow -13.59%-5.84B105.32%20M-202.96%-3.58B42.89%-253M35.39%-2.03B-138.17%-5.14B28.38%-376M-116.70%-1.18B-5.73%-443M---3.14B
Financing cash flow
Cash flow from continuing financing activities -87.49%-6.79B-156.72%-3.67B-164.15%-1.19B92.10%-115M29.81%-1.82B-28.90%-3.62B-159.72%-1.43B1,328.48%1.86B23.57%-1.46B-2.59B
Net issuance payments of debt -1,450.32%-2.4B-91.42%-2.5B-156.14%-1.11B99.92%-1M139.09%1.21B-123.70%-155M-137.44%-1.31B197,300.00%1.97B27.40%-1.33B--504M
Net common stock issuance -33.33%-4B---1B--0--00.00%-3B0.00%-3B--0--0--0---3B
Cash dividends paid -11.47%-583M-9.56%-149M-11.11%-150M-10.37%-149M-15.38%-135M-14.95%-523M-16.24%-136M-14.41%-135M-15.38%-135M---117M
Net other financing activities 246.43%194M-221.43%-17M272.22%67M775.00%35M445.00%109M722.22%56M-30.00%14M156.25%18M-89.19%4M--20M
Cash from discontinued financing activities
Financing cash flow -87.52%-6.79B-156.72%-3.67B-164.15%-1.19B92.10%-115M29.77%-1.82B-28.90%-3.62B-159.72%-1.43B1,328.48%1.86B23.57%-1.46B---2.59B
Net cash flow
Beginning cash position -5.15%8.1B-24.29%4.67B125.09%7.1B57.69%5.52B-5.15%8.1B90.09%8.54B110.22%6.17B65.51%3.15B25.94%3.5B--8.54B
Current changes in cash -1,007.82%-3.97B-118.60%-357M-184.26%-2.6B543.73%1.59B48.06%-2.6B-108.55%-358M-64.15%1.92B148.83%3.09B54.90%-359M---5.01B
Effect of exchange rate changes -10.98%-91M-2,830.00%-273M339.73%175M-225.00%-15M170.97%22M41.01%-82M-96.00%10M65.57%-73M115.38%12M---31M
End cash Position -50.10%4.04B-50.10%4.04B-24.29%4.67B125.09%7.1B57.69%5.52B-5.15%8.1B-5.15%8.1B110.22%6.17B65.51%3.15B--3.5B
Free cash flow 4.91%7.27B-15.31%2.81B-9.03%1.89B32.09%1.66B233.58%904M0.23%6.93B12.97%3.32B49.78%2.08B22.90%1.26B--271M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MARA Holdings
MARA
+10.12%
Coinbase
COIN
+0.85%
Apple
AAPL
+0.13%
Adobe
ADBE
-0.16%
Toll Brothers
TOL
-0.46%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.22%
Robotics
Robotics
Intraday-1.52%